Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium
Journal article published in 2019 by
Isabelle Ray-Coquard,
Ioana Braicu,
Regina Berger,
Sven Mahner,
Jalid Sehouli,
Eric Pujade-Lauraine,
Philippe Alexandre Cassier,
Ute Martha Moll,
Hanno Ulmer,
Karin Leunen,
Alain Gustave Zeimet,
Christian Marth,
Ignace Vergote,
Nicole Concin 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 